rs398124607
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001291867.2(NHS):c.302_337dup(p.Glu101_Ala112dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000467 in 1,055,580 control chromosomes in the GnomAD database, including 1 homozygotes. There are 173 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00050 ( 0 hom., 8 hem., cov: 23)
Exomes 𝑓: 0.00046 ( 1 hom. 165 hem. )
Consequence
NHS
NM_001291867.2 inframe_insertion
NM_001291867.2 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0890
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 8 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.302_337dup | p.Glu101_Ala112dup | inframe_insertion | 1/9 | ENST00000676302.1 | |
NHS | NM_198270.4 | c.302_337dup | p.Glu101_Ala112dup | inframe_insertion | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.302_337dup | p.Glu101_Ala112dup | inframe_insertion | 1/9 | NM_001291867.2 | P4 | ||
NHS | ENST00000380060.7 | c.302_337dup | p.Glu101_Ala112dup | inframe_insertion | 1/8 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000504 AC: 56AN: 111219Hom.: 0 Cov.: 23 AF XY: 0.000237 AC XY: 8AN XY: 33751
GnomAD3 genomes
AF:
AC:
56
AN:
111219
Hom.:
Cov.:
23
AF XY:
AC XY:
8
AN XY:
33751
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000463 AC: 437AN: 944326Hom.: 1 Cov.: 30 AF XY: 0.000552 AC XY: 165AN XY: 298806
GnomAD4 exome
AF:
AC:
437
AN:
944326
Hom.:
Cov.:
30
AF XY:
AC XY:
165
AN XY:
298806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000503 AC: 56AN: 111254Hom.: 0 Cov.: 23 AF XY: 0.000237 AC XY: 8AN XY: 33798
GnomAD4 genome
AF:
AC:
56
AN:
111254
Hom.:
Cov.:
23
AF XY:
AC XY:
8
AN XY:
33798
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 01, 2022 | In-frame insertion of 12 amino acids in a non-repeat region; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 03, 2014 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 31, 2017 | - - |
Nance-Horan syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jan 02, 2024 | This variant, c.302_337dup, results in the insertion of 12 amino acid(s) of the NHS protein (p.Glu101_Ala112dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs398124607, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with NHS-related conditions. ClinVar contains an entry for this variant (Variation ID: 96638). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at